Archive for the ‘Bioprocessing’ Category
Wednesday, March 14th, 2012
-
-
SAFC sponsors the Informex Networking Lounge
-
-
The SAFC Booth at Informex 2012
-
-
SAFC partners with Rx-360 and Informex to support Habitat for Humanity in NOLA
It is hard to believe that Informex 2012 is already a month behind us. SAFC spent a productive week at the Morial Convention Center in New Orleans, LA with industry colleagues old and new. SAFC was not only an exhibitor and presenter at the show, but also took involvement one step further through a social media sponsorship that included sponsoring the Informex Networking Lounge. Over the three days in NOLA, the Lounge offered attendees with a place to meet, network and participate in social media.
(more…)
Posted in Bioprocessing, CMOs, Continuous Processing - Microreators, HPAPIs, Industry Overview, Media Production, Quality, Regulatory, Supply Chain, Technologies, ZFN | No Comments »
Thursday, February 9th, 2012
SAFC is just a few days away from arriving in New Orleans for Informex 2012. As an exhibitor and sponsor of the Informex Networking Lounge, SAFC will have various members of the executive and sales team onsite to discuss SAFC capabilities and technologies. In particular, SAFC will be available to discuss their capabilities surrounding the creation of antibody – drug conjugates (ADCs) which have recently received a lot of press as they become more relevant to the chemical and pharma industry.
Because of their potency, ADCs require a different level of manufacturing capabilities, and SAFC is one of a handful of companies that has made large investments in GMP manufacturing capabilities for antibody – drug conjugates. Here, SAFC Process Development Manager, Michael Bienkowski, talks to us about the ADC market and future prospects for SAFC in this area.
(more…)
Posted in Bioconjugation, biology, Bioprocessing, CMOs, Technologies | No Comments »
Wednesday, February 1st, 2012
Today, Sigma Aldrich confirmed that the newly acquired BioReliance business will become part of SAFC, the custom manufacturing and services business unit of Sigma-Aldrich. SAFC President, Gilles Cottier noted that the acquisition would serve to increase the SAFC value proposition and positively leverage the company’s industrial media presence and biological testing capabilities for end user services and solutions.
(more…)
Posted in biology, Bioprocessing, CMOs, Fine Chemicals, Industry Overview, Media Production, Quality, Regulatory | No Comments »
Monday, January 9th, 2012
Today, Sigma-Aldrich Corporation announced plans to acquire BioReliance Holdings for $350M. The acquisition is part of a strategic plan to extend the company’s biopharmaceutical testing and services and increase their value proposition to customers. The extension of these services will allow Sigma-Aldrich to more effectively provide enhanced solutions for its biopharmaceutical customers and also allows customers to work with a single point provider that is more vertically integrated throughout the drug discovery process. The full press release is available by clicking below. Stay tuned to SAFC Live as we provide updates on this new acquisition and what it means for the company and the industry.
(more…)
Posted in Bioprocessing, CMOs, Industry Overview | No Comments »
Thursday, October 27th, 2011
Following the introduction of the CHO cell line earlier this year in July, SAFC has just announced the release of a novel CHOZN® GS-/- Zinc Finger Nuclease (ZFN)- modified Chinese Hamster Ovary (CHO) cell line. Designed for use in the production of biopharmaceuticals, the new CHOZN GS-/- cell line is the first commercially available glutamine synthetase (GS) knockout CHO cell line proven to shorten bioproduction times in early development, enabling customers to enhance their speed-to-market and increase cost efficiency. Read more about it on Manufacturing Chemist by clicking here.
Posted in Bioprocessing, Cell biology, CMOs, Industry Overview, Media Production, ZFN | No Comments »
Wednesday, September 28th, 2011
The September/October issue of Pharma Magazine features an article authored by Bruce Lehr, SAFC Director of Development and Kevin Kayser, SAFC Associate Director of Cell Engineering which discusses using a platform development and manufacturing strategy to control operations across biopharmaceutical projects. The article further discusses SAFC’s ZFN (Zinc Finger Nuclease) technology which allows for the isolation of genes for modification. Please take a moment to read the full story here.
Posted in Bioprocessing, Cell biology, CMOs, Industry Overview, Quality, Supply Chain, ZFN | No Comments »
Tuesday, August 9th, 2011
As promised, we return with a new perspective on the Stellar Biotechnologies and SAFC partnership. On August 3rd, Stellar announced SAFC as a partner for the supply of keyhole limpet hemocyanin (KLH), an important component of several vaccines that are in development. In this segment, Stellar President and Chief Executive Officer, Frank Oakes, explains how it produces KLH, and why the partnership is good for both companies.
(more…)
Posted in Bioconjugation, biology, Bioprocessing, CMOs | No Comments »
